Off Label NCCN denied due to quantity / dose limits by Humana?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for off label nccn are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Off Label NCCN
## Why Humana Imposed Quantity Limits on This Off-Label (NCCN-Supported) Drug
Quantity-limit (QL) denials mean Humana's plan will cover the drug, but only up to a defined supply amount per fill or per period. When the prescribed quantity exceeds that limit — which is common in oncology where dosing is individualized to body surface area, organ function, or treatment protocol — the excess quantity is denied. The QL in Humana's formulary is set for the FDA-approved indication and standard dosing, and it may not reflect the regimen your oncologist has prescribed for your off-label use.
## Why This Is Appealable
Quantity limits are administrative benchmarks, not clinical determinations for your individual case. When your prescriber has documented a specific regimen — based on the applicable NCCN protocol and your individual clinical parameters — that requires a quantity exceeding the limit, a quantity-limit exception is the appropriate remedy. These appeals succeed when the prescriber clearly documents why the prescribed quantity is medically necessary for this patient.
## Federal Appeal Framework
- Quantity-limit exception request: File this simultaneously with or before a formal appeal; it is often resolved faster. Ask Humana's pharmacy team for the exception request form.
- Formal internal appeal: If the exception is denied, file a written appeal within the timeframe on your EOB. Request Humana's published QL criteria and the basis for the limit.
- External review (ACA §2719): After final internal denial, IRO review is available. Standard window is approximately four months; expedited review for urgent situations.
- ERISA §503 (employer plans): Request the specific QL policy and all clinical criteria used in the review.
## Documentation to Gather
1. Prescriber's prescribed regimen — a written order showing the drug, prescribed quantity per cycle, and dosing rationale (e.g., body surface area calculation, organ-function adjustment per the FDA label or NCCN protocol). 2. NCCN protocol citation — the applicable NCCN regimen specification for this drug and indication. 3. Treatment calendar — the planned cycle schedule showing why the requested quantity is necessary over the coverage period. 4. Prescriber medical-necessity letter — explicitly stating that the prescribed quantity is the minimum necessary for this patient's regimen. 5. Humana's QL policy — obtain the published quantity limit and exception criteria to address each requirement.
## Criteria-Mapping Structure
List Humana's quantity-limit exception criteria one by one. For each, provide the prescriber's documented rationale, the treatment calendar, and the NCCN protocol reference. Attach these as labeled exhibits. Emphasize that the excess quantity is not a convenience request — it is the minimum required for a complete treatment cycle as prescribed.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →